BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA
Share price & Turnover
Subscription
Description
| Country | Finland |
|---|---|
| List | First North Finland |
| Sector | Health care |
| Industry | Medical technology |
BBS-Bioactive Bone Substitutes Plc | Company Release | June 04, 2024 at 17:45:00 EEST
Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA
Claims for BBS-Bioactive Bone Substitutes Plc's (“Company”) complementary patent application for “A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION” have been approved in the United States. These claims are related to ARTEBONE®-product and its use in the treatment method.
The Company will notify the US patent office that it approves the decision. The patent office will grant the patent after the approval of the Company.
CEO Juliusz Rakowski: “This patent significantly supplements the patent protection of the ARTEBONE® bone substitute.“
This is the second supplementary patent that the Company has applied for in the USA. Patents in the USA have previously been announced:
- January 11, 2022 US Patent for the Manufacture of ARTEBONE® product
- November 17, 2021 Claims of the patent application for the manufacturing of the ARTEBONE® product have been approved in the USA
- April 7, 2020 The patent regarding the product ARTEBONE® has been granted in the USA